FNDC5 and early-onset autosomal dominant Alzheimer disease: FNDC5/irisin levels are reduced in the hippocampi of patients with Alzheimer’s disease (AD) and in experimental models, with evidence suggesting that increasing these levels can restore synaptic plasticity and improve memory [78].